LEADER 02047nmm a2200457 u 4500
001 EB001871969
003 EBX01000000000000001035340
005 00000000000000.0
007 cr|||||||||||||||||||||
008 190824 ||| eng
100 1 |a Richardson, Paul G. 
245 0 0 |a The evolving role of novel and next generation therapies in the management of multiple myeloma  |h Elektronische Ressource  |b part 2 of 2, relapse refractory multiple myeloma  |c Paul G. Richardson 
246 3 1 |a Evolving role of novel and next generation therapies in the management of multiple myeloma. Part 2, Relapse refractory multiple myeloma 
260 |a London  |b Henry Stewart Talks  |c 2019, 2019 
300 |a 1 streaming video file (19 min.)  |b color, sound 
505 0 |a T-cell therapy strategies for Multiple Myeloma -- Cell-based Myeloma vaccines -- Antibody-drug conjugates -- Continuing evolution of Multiple Myeloma treatment 
653 |a Immunotherapy / trends 
653 |a Multiple Myeloma / therapy 
653 |a Bortezomib 
653 |a Antibodies, Monoclonal / therapeutic use 
653 |a Drug Discovery 
653 |a isatuximab 
653 |a Cancer Vaccines 
653 |a Multiple Myeloma / drug therapy 
653 |a Multiple Myeloma / immunology 
653 |a Immunoconjugates / therapeutic use 
653 |a Receptors, Antigen, T-Cell / therapeutic use 
653 |a Multiple myeloma / Treatment 
653 |a Antineoplastic Agents / therapeutic use 
653 |a Antibody-drug conjugates 
653 |a Recurrence 
653 |a Antineoplastic agents 
653 |a elotuzumab 
653 |a T-Lymphocytes / immunology 
653 |a Multiple myeloma / Chemotherapy 
041 0 7 |a eng  |2 ISO 639-2 
989 |b HST  |a Henry Stewart Talks 
490 0 |a The biomedical & life sciences collection 
500 |a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web 
856 4 0 |u https://hstalks.com/bs/3990  |x Verlag  |z Streaming video file 
082 0 |a 570